Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Ethnopharmacol ; 137(1): 652-61, 2011 Sep 01.
Article in English | MEDLINE | ID: mdl-21718774

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: The use of an aqueous extract of coriander (Coriandrum sativum L.; Apiaceae, Umbelliferae) seeds (CS-extract) in Moroccan traditional treatment of diabetes remains to be experimentally validated. AIM OF THE STUDY: The study aim was to investigate potential hypoglycemic (and hypolipidemic) activity of CS-extract after a single oral dose and after daily dosing for 30 days (sub-chronic study) in normal and obese-hyperglycemic-hyperlipidemic (OHH) Meriones shawi rats. MATERIALS AND METHODS: After a single oral dose of CS-extract (20mg/kg; predetermined as optimum), plasma glucose, insulin, total cholesterol (TC), and triglycerides (TG) were measured in normal and OHH rats (hypercaloric diet and forced limited physical activity); glibenclamide (GLB; 2.5mg/kg) was used as reference. In the sub-chronic study, the effect of CS-extract and GLB (at the above doses) on body weight (BW), plasma glucose, insulin, TC, LDL-cholesterol, HDL-cholesterol, TG, urea and creatinine was determined in normal and OHH rats; insulin resistance (IR as HOMA-IR), atherosclerotic and cardioprotective indices were calculated. RESULTS: A single dose of CS-extract or GLB suppressed hyperglycemia in OHH rats, and normo-glycemia was achieved at 6-h post-dose; there was no effect on lipids, TG or insulin, but IR decreased significantly. The hypoglycemic effect was lower in normal rats. In the sub-chronic study in OHH rats, the test substances (CS-extract>GLB) reduced plasma glucose (normoglycemia on Day 21), insulin and IR, TC, LDL-cholesterol, and TG. Atherosclerotic index decreased while cardioprotective indices increased only by CS-extract, with no effect on BW, urea or creatinine. CONCLUSION: Sub-chronic administration of CS-extract in OHH Meriones shawi rats normalized glycemia and decreased the elevated levels of insulin, IR, TC, LDL-cholesterol and TG. Since, the CS-extract decreased several components of the metabolic syndrome and decreased atherosclerotic and increased cardioprotective indices, CS-extract may have cardiovascular protective effect. The present study validates the traditional use of coriander in diabetes.


Subject(s)
Atherosclerosis/prevention & control , Coriandrum , Hyperglycemia/drug therapy , Hypoglycemic Agents/pharmacology , Hypolipidemic Agents/pharmacology , Obesity/drug therapy , Plant Extracts/pharmacology , Administration, Oral , Animals , Atherosclerosis/blood , Atherosclerosis/etiology , Biomarkers/blood , Blood Glucose/drug effects , Blood Glucose/metabolism , Body Weight/drug effects , Coriandrum/chemistry , Creatinine/blood , Disease Models, Animal , Dose-Response Relationship, Drug , Gerbillinae , Hyperglycemia/blood , Hyperglycemia/complications , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/isolation & purification , Hypolipidemic Agents/administration & dosage , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/isolation & purification , Insulin/blood , Insulin Resistance , Lipids/blood , Male , Obesity/blood , Obesity/complications , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plants, Medicinal , Seeds , Solvents/chemistry , Time Factors , Urea/blood , Water/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL